{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:55:40Z","timestamp":1740135340170,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Paediatric patients are especially prone to experiencing adverse drug reactions (ADRs), and the surgical environment gathers many conditions for such reactions to occur. Additionally, little information exists in the literature on ADRs in the paediatric surgical population. We aimed to quantify the ADR frequency in this population, and to investigate the characteristics and risk factors associated with ADR development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective observational study was conducted in a cohort of 311 paediatric patients, aged 1\u201316 years, admitted for surgery at a tertiary referral hospital in Spain (2019\u20132021). Incidence rates were used to assess ADR frequency. Odds ratios (ORs) were calculated to evaluate the influence of potential risk factors on ADR development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Distinct ADRs (103) were detected in 80 patients (25.7%). The most frequent being hypotension (<jats:italic>N<\/jats:italic>\u2009=\u200932; 35%), nausea (<jats:italic>N<\/jats:italic>\u2009=\u200916; 15.5%), and emergence delirium (<jats:italic>N<\/jats:italic>\u2009=\u200916; 15.5%). Most ADRs occurred because of drug-drug interactions. The combination of sevoflurane and fentanyl was responsible for most of these events (<jats:italic>N<\/jats:italic>\u2009=\u200932; 31.1%). The variable most robustly associated to ADR development, was the number of off-label drugs prescribed per patient (OR\u2009=\u20092.99; 95% CI 1.73 to 5.16), followed by the number of drugs prescribed per patient (OR\u2009=\u20091.26, 95% CI 1.13 to 1.41), and older age (OR\u2009=\u20091.26, 95% CI 1.07 to 1.49). The severity of ADRs was assessed according to the criteria of Venulet and the Spanish Pharmacovigilance System. According to both methods, only four ADRs (3.9%) were considered serious.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ADRs have a high incidence rate in the paediatric surgical population. The off-label use of drugs is a key risk factor for ADRs development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-024-04803-1","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:01:30Z","timestamp":1715997690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-0383","authenticated-orcid":false,"given":"C","family":"P\u00e9rez-Ingidua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-4583","authenticated-orcid":false,"given":"AB","family":"Rivas-Paterna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0715-055X","authenticated-orcid":false,"given":"C","family":"Gonz\u00e1lez-Perrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0333-6242","authenticated-orcid":false,"given":"E","family":"Aleo-Luj\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9159-3520","authenticated-orcid":false,"given":"A","family":"Ascaso-del-Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-691X","authenticated-orcid":false,"given":"L","family":"Laredo-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-5275","authenticated-orcid":false,"given":"A","family":"Portol\u00e9s-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-6004","authenticated-orcid":false,"given":"E","family":"Vargas-Castrill\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"4803_CR1","first-page":"361","volume":"6","author":"E Fern\u00e1ndez-de Uzquiano","year":"2008","unstructured":"Fern\u00e1ndez-de Uzquiano E, Gil-aguado P, Lavilla-uriol A. Ensayos cl\u00ednicos en pediatr\u00eda (I). Pediatr\u00eda Contin. 2008;6:361\u20133.","journal-title":"Pediatr\u00eda Contin"},{"key":"4803_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(96)91182-4","volume":"347","author":"S Turner","year":"1996","unstructured":"Turner S, Gill A, Nunn T, Hewitt B, Choonara I. Use of \u2018off-label\u2019 and unlicensed drugs in paediatric intensive care unit. Lancet. 1996;347:549\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(96)91182-4","journal-title":"Lancet"},{"key":"4803_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.aprim.2014.07.010","volume":"47","author":"E Blanco-Reina","year":"2015","unstructured":"Blanco-Reina E, Vega-Jim\u00e9nez MA, Oca\u00f1a-Riola R, M\u00e1rquez-Romero EI, Bellido-Est\u00e9vez I. Drug prescriptions study in the outpatient setting: assessment of off-label uses in children. Aten Primaria. 2015;47:344\u201350. https:\/\/doi.org\/10.1016\/j.aprim.2014.07.010","journal-title":"Aten Primaria"},{"key":"4803_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-014-1768-9","volume":"71","author":"J Magalh\u00e3es","year":"2014","unstructured":"Magalh\u00e3es J, Teixeira Rodrigues A, Roque F, Figueiras A, Falc\u00e3o A, Herdeiro MT. Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol. 2014;71:1\u201313. https:\/\/doi.org\/10.1007\/s00228-014-1768-9","journal-title":"Eur J Clin Pharmacol"},{"key":"4803_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1365-2125.2002.t01-3-01689.x","volume":"54","author":"B Horen","year":"2002","unstructured":"Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54:665\u201370. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.t01-3-01689.x","journal-title":"Br J Clin Pharmacol"},{"key":"4803_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/pds.858","volume":"13","author":"M Ufer","year":"2004","unstructured":"Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:147\u201352. https:\/\/doi.org\/10.1002\/pds.858","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4803_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40272-016-0201-5","volume":"19","author":"AD Moore","year":"2017","unstructured":"Moore AD, Anghelescu DL. Emergence delirium in pediatric anesthesia. Pediatr Drugs. 2017;19:11\u201320. https:\/\/doi.org\/10.1007\/s40272-016-0201-5","journal-title":"Pediatr Drugs"},{"key":"4803_CR8","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s12325-020-01317-x","volume":"37","author":"I Urits","year":"2020","unstructured":"Urits I, Peck J, Giacomazzi S, Patel R, Wolf J, Mathew D, et al. Emergence delirium in perioperative pediatric care: a review of current evidence and new directions. Adv Ther. 2020;37:1897\u2013909. https:\/\/doi.org\/10.1007\/s12325-020-01317-x","journal-title":"Adv Ther"},{"key":"4803_CR9","doi-asserted-by":"publisher","unstructured":"M Dittrich AT, T Draaisma JM, van Puijenbroek EP, WM te Loo M. Analysis of reporting adverse drug reactions in paediatric patients in a university hospital in the Netherlands. Pediatr Drugs 2020;22:425\u201332. https:\/\/doi.org\/10.1007\/s40272-020-00405-3","DOI":"10.1007\/s40272-020-00405-3"},{"key":"4803_CR10","first-page":"9","volume":"6","author":"J Rodr\u00edguez-Terrones","year":"2013","unstructured":"Rodr\u00edguez-Terrones J, Aguilar-Armas J, Arana-Delgado J. Reacciones adversas medicamentosas durante El Acto anest\u00e9sico en pacientes sometidos a cirug\u00eda electiva en El Centro quir\u00fargico Del Hospital Almanzor Aguinaga Asenjo De Octubre 2008 \u2013 marzo 2009. Rev Cuerpo M\u00e9dico HNAAA. 2013;6:9\u201316.","journal-title":"Rev Cuerpo M\u00e9dico HNAAA"},{"key":"4803_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/bja\/aep376","volume":"104","author":"S Dahmani","year":"2010","unstructured":"Dahmani S, Stany I, Brasher C, Lejeune C, Bruneau B, Wood C, et al. Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: a meta-analysis of published studies. Br J Anaesth. 2010;104:216\u201323. https:\/\/doi.org\/10.1093\/bja\/aep376","journal-title":"Br J Anaesth"},{"key":"4803_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40521-016-0078-0","volume":"3","author":"LH Garvey","year":"2016","unstructured":"Garvey LH. Perioperative hypersensitivity reactions: diagnosis, treatment and evaluation. Curr Treat Options Allergy. 2016;3:113\u201328. https:\/\/doi.org\/10.1007\/s40521-016-0078-0","journal-title":"Curr Treat Options Allergy"},{"key":"4803_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1399-6576.2007.01489.x","volume":"52","author":"JM Malinovsky","year":"2008","unstructured":"Malinovsky JM, Decagny S, Wessel F, Guilloux L, Mertes PM. Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients. Acta Anaesthesiol Scand. 2008;52:175\u201381. https:\/\/doi.org\/10.1111\/j.1399-6576.2007.01489.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"4803_CR14","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.bja.2019.04.044","volume":"123","author":"LH Garvey","year":"2019","unstructured":"Garvey LH, Dewachter P, Hepner DL, Mertes PM, Voltolini S, Clarke R, et al. Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations. Br J Anaesth. 2019;123:e50\u201364. https:\/\/doi.org\/10.1016\/j.bja.2019.04.044","journal-title":"Br J Anaesth"},{"key":"4803_CR15","unstructured":"Lawson D. Intensive monitoring studies in hospitals - I: Boston collaborative drug surveillance program. En: Inman WHW, ed. Monitoring for drug safety, 2.a ed. Lancaster: MTP Press, 1986: 255\u2009\u2013\u200976. n.d."},{"key":"4803_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/CLPT.1981.154","volume":"30","author":"C Naranjo","year":"1981","unstructured":"Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345. https:\/\/doi.org\/10.1038\/CLPT.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"4803_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cpt1977213247","volume":"21","author":"FE Karch","year":"1977","unstructured":"Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977;21:247\u201354. https:\/\/doi.org\/10.1002\/cpt1977213247","journal-title":"Clin Pharmacol Ther"},{"key":"4803_CR18","doi-asserted-by":"crossref","unstructured":"Venulet J. Methods of monitoring adverse reactions to drugs. Prog Drug Res 1977:233\u201374.","DOI":"10.1007\/978-3-0348-7098-6_3"},{"key":"4803_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Harvald B, Gram LF, Grodum E, Br\u00f8sen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228:83\u201390. https:\/\/doi.org\/10.1111\/j.1365-2796.1990.tb00199.x","journal-title":"J Intern Med"},{"key":"4803_CR20","first-page":"18","volume-title":"Textb. Advers. Drug React","author":"M Rawlins","year":"1991","unstructured":"Rawlins M, Thompson J. Mechanisms of adverse drug reactions. In: Davies D, editor. Textb. Advers. Drug React. Oxford: Oxford University Press; 1991. pp. 18\u201345."},{"key":"4803_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/archdischild-2015-309396","volume":"101","author":"AB Rivas","year":"2016","unstructured":"Rivas AB, Arruza L, Pacheco E, Portoles A, Diz J, Vargas E. Adverse drug reactions in neonates: a prospective study. Arch Dis Child. 2016;101:371\u20136. https:\/\/doi.org\/10.1136\/archdischild-2015-309396","journal-title":"Arch Dis Child"},{"key":"4803_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"J Landis","year":"1977","unstructured":"Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159. https:\/\/doi.org\/10.2307\/2529310","journal-title":"Biometrics"},{"key":"4803_CR23","first-page":"245","volume":"3\u20134","author":"J Aranda","year":"1983","unstructured":"Aranda J. Factors associated with adverse drug reactions in the newborn. Pediatr Pharmacol (New York). 1983;3\u20134:245\u20139.","journal-title":"Pediatr Pharmacol (New York)"},{"key":"4803_CR24","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1111\/bcp.15150","volume":"88","author":"AA Alghamdi","year":"2022","unstructured":"Alghamdi AA, Keers RN, Sutherland A, Hann M, Gray J, Mason G, et al. Incidence and nature of adverse drug events in paediatric intensive care units: a prospective multicentre study. Br J Clin Pharmacol. 2022;88:2213\u201322. https:\/\/doi.org\/10.1111\/bcp.15150","journal-title":"Br J Clin Pharmacol"},{"key":"4803_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2012-001868","volume":"3","author":"DCB Silva","year":"2013","unstructured":"Silva DCB, Ribeiro Araujo O, Arduini RG, Alonso CFR, Shibata AR, Troster EJ. Adverse drug events in a paediatric intensive care unit: a prospective cohort. BMJ Open. 2013;3:1\u20137. https:\/\/doi.org\/10.1136\/bmjopen-2012-001868","journal-title":"BMJ Open"},{"key":"4803_CR26","unstructured":"Miller RD, Cohen NH, Eriksson LI, Fleisher LA, Wiener-Kronish JPYW. Miller\u2019s Anesthesia. 9th ed. Elsevier; 2021."},{"key":"4803_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s11096-021-01249-8","volume":"43","author":"S Feitosa Ramos","year":"2021","unstructured":"Feitosa Ramos S, De Castro Ara\u00fajo-Neto F, Targino Aires-Moreno G, Souza Anacleto de Ara\u00fajo DC, Da Costa Lima E, Pereira de Lyra D. Causality and avoidability of adverse drug reactions of antibiotics in hospitalized children: a cohort study. Int J Clin Pharm. 2021;43:1293\u2013301. https:\/\/doi.org\/10.1007\/s11096-021-01249-8","journal-title":"Int J Clin Pharm"},{"key":"4803_CR28","doi-asserted-by":"publisher","unstructured":"Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11. https:\/\/doi.org\/10.1186\/1741-7015-11-237","DOI":"10.1186\/1741-7015-11-237"},{"key":"4803_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/01.CCM.0000049947.80131.ED","volume":"31","author":"E Vargas","year":"2003","unstructured":"Vargas E, Terleira A, Hernando F, Perez E, Cord\u00f3n C, Moreno A, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med. 2003;31:694\u20138. https:\/\/doi.org\/10.1097\/01.CCM.0000049947.80131.ED","journal-title":"Crit Care Med"},{"key":"4803_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2710.2006.00744.x","volume":"31","author":"E Davies","year":"2006","unstructured":"Davies E, Green C, Mottram D, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther. 2006;31:335\u201341. https:\/\/doi.org\/10.1111\/j.1365-2710.2006.00744.x","journal-title":"J Clin Pharm Ther"},{"key":"4803_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1824-7288-36-4","volume":"36","author":"E Napoleone","year":"2010","unstructured":"Napoleone E. Children and ADRs (adverse drug reactions). Ital J Pediatr. 2010;36:1\u20135. https:\/\/doi.org\/10.1186\/1824-7288-36-4","journal-title":"Ital J Pediatr"},{"key":"4803_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5863\/1551-6776-24.1.4","volume":"24","author":"M Rieder","year":"2019","unstructured":"Rieder M. Adverse drug reactions in children: Pediatric pharmacy and drug safety. J Pediatr Pharmacol Ther. 2019;24:4\u20139. https:\/\/doi.org\/10.5863\/1551-6776-24.1.4","journal-title":"J Pediatr Pharmacol Ther"},{"key":"4803_CR33","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1651-2227.1999.tb00191.x","volume":"88","author":"S Turner","year":"2007","unstructured":"Turner S, Nunn A, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 2007;88:965\u20138. https:\/\/doi.org\/10.1111\/j.1651-2227.1999.tb00191.x","journal-title":"Acta Paediatr"},{"key":"4803_CR34","doi-asserted-by":"publisher","unstructured":"Camacho Arroyo MT, Rivas Paterna AB, Meneses Monroy A, Cabrera Garc\u00eda L, Bl\u00e1zquez Gonz\u00e1lez, Mancebo Salas N, Rodr\u00edguez Leal L et al. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study. Arch Argent Pediatr 2022:4\u201311. https:\/\/doi.org\/10.5546\/aap.2021-02550.eng","DOI":"10.5546\/aap.2021-02550.eng"},{"key":"4803_CR35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2165\/00002018-200427130-00006","volume":"27","author":"A Neubert","year":"2004","unstructured":"Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf. 2004;27:1059\u201367. https:\/\/doi.org\/10.2165\/00002018-200427130-00006","journal-title":"Drug Saf"},{"key":"4803_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4103\/ija.IJA_487_19","volume":"63","author":"M Maheshwari","year":"2019","unstructured":"Maheshwari M, Sanwatsarkar S, Katakwar M. Pharmacology related to paediatric anaesthesia. Indian J Anaesth. 2019;63:698\u2013706. https:\/\/doi.org\/10.4103\/ija.IJA_487_19","journal-title":"Indian J Anaesth"},{"key":"4803_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.ANPEDI.2013.10.004","volume":"81","author":"R Pi\u00f1eiro P\u00e9rez","year":"2014","unstructured":"Pi\u00f1eiro P\u00e9rez R, Ruiz Antor\u00e1n MB, Avenda\u00f1o Sol\u00e1 C, Rom\u00e1n Riechmann E, Cabrera Garc\u00eda L, Cilleruelo Ortega MJ, et al. Conocimiento Sobre El uso de f\u00e1rmacos off-label en Pediatr\u00eda. Resultados De una encuesta pedi\u00e1trica nacional 2012\u20132013 (estudio OL-PED). Pediatr\u00eda. 2014;81:16\u201321. https:\/\/doi.org\/10.1016\/J.ANPEDI.2013.10.004","journal-title":"Pediatr\u00eda"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04803-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:01:47Z","timestamp":1715997707000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04803-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4803"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04803-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Hospital Cl\u00ednico San Carlos (code:18\/340-E). Written informed parental consent was obtained for all patients included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}